Efficiency of Traumeel S Application in Combined Therapy of Acute Sinusitis in Children

Abstract

The article presents the results of researches on the effect of combination bioregulatory drug Traumeel S, manufactured by Biologische Heilmittel Heel GmbH, on the clinical efficacy of treatment for acute sinusitis in children on the background of basic therapy. Evaluation of treatment efficacy was performed by determining the integrated hematological indices, calculated on the basis of indicators of clinical blood tests and markers of inflammation (total protein and its fractions, C-reactive protein). The inclusion of Traumeel S into the treatment regimens in patients with acute sinusitis showed significantly more rapid decline in leukocyte index of intoxication, and the completion of inflammation. This medicine is effective and well tolerated by patients.

Keywords

• acute sinusitis
• children
• syndrome of endogenous intoxication
• leukocyte index of intoxication
• index of white blood cells shift
• C-reactive protein
• Traumeel S